Attention-Deficit/Hyperactivity Disorder (ADHD)

CADDRA Guidelines

• Canadian guidelines on management of ADHD

Medication Chart

• Summary of medications avaliable in Canada

DSM-5 Criteria

• Diagnostic criteria for ADHD

1. The following are signs/symptoms consistent with ADHD EXCEPT: 

a) difficulty paying attention to details 

b) low mood 

c) difficulty sitting still

d) fidgeting 

2. Which of the following is NOT considered a risk factor for ADHD?

a) genetics 

b) low birth weight 

c) poor parenting 

d) alcohol use in pregnancy  

3. Which of the following is NOT one of the three core symptoms of ADHD?

a) Inattention 

b) Hyperactivity  

c) Impulsivity  

d) Overachievement  

4. Which of the following is a first-line treatment option for ADHD? 

a) Guanfacine

b) Atomoxetine  

c) Dexedrine IR 

d) Bupropion  

5. Patient AD is starting on Vyvanse 20 mg once daily. What is the recommended trial period to assess its efficacy? 

a) 2-3 days 

b) 1 week

c) 3-4 weeks

d) 2-3 months